This study aims to explore the potential of FAPI PET in evaluating cardiac remodeling, with a focus on its ability to assess dynamic changes in FAP expression in a mouse model of hypertensive heart disease and the reversion of FAP-positive fibroblasts to a FAP-negative state after the discontinuation of hypertension-inducing agents. Here, FAP is linked to hypertensive disorder.